| Product Code: ETC13276290 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Gastric Ulcers Market was valued at USD 1.2 Billion in 2024 and is expected to reach USD 1.8 Billion by 2031, growing at a compound annual growth rate of 5.30% during the forecast period (2025-2031).
The Global Gastric Ulcers Market is expected to experience steady growth in the coming years, driven by factors such as the increasing prevalence of gastric ulcers, rising geriatric population, and unhealthy dietary habits. Technological advancements in diagnostic techniques and treatment options are also contributing to market growth. The market is segmented based on treatment type, including medication, surgery, and endoscopy procedures. North America currently leads the market due to high healthcare expenditure and advanced medical infrastructure, while emerging economies in Asia-Pacific are expected to witness rapid growth due to improving healthcare facilities and increasing awareness about gastrointestinal disorders. Key players in the market include AstraZeneca, Takeda Pharmaceutical Company, and Pfizer Inc., who are investing in research and development to introduce innovative therapies for gastric ulcers.
The Global Gastric Ulcers Market is experiencing a trend towards the adoption of minimally invasive procedures for diagnosis and treatment, such as endoscopy and laparoscopy. This shift is driven by the increasing preference for less invasive and more precise techniques that offer faster recovery times and improved patient outcomes. Additionally, there is a growing focus on developing innovative pharmaceutical therapies for gastric ulcers, including the use of proton pump inhibitors and antibiotics to target Helicobacter pylori infections. Opportunities in the market include expanding research and development efforts to identify novel treatment options, as well as leveraging advancements in technology to enhance diagnostic capabilities. With the rising burden of gastric ulcers worldwide, there is a significant opportunity for healthcare providers and pharmaceutical companies to address unmet needs and improve patient care.
The Global Gastric Ulcers Market faces several challenges, including the high prevalence of Helicobacter pylori infection as a leading cause of gastric ulcers, increasing resistance to conventional treatments such as proton pump inhibitors, and the lack of awareness about preventive measures among the general population. Additionally, the presence of alternative treatment options, such as herbal remedies and dietary supplements, further complicates the market landscape. Furthermore, regulatory hurdles and the high cost of treatment options pose significant challenges for market growth and accessibility, particularly in developing regions. Overall, addressing these challenges will require innovative approaches in research and development, as well as improved healthcare infrastructure and education to effectively manage and reduce the burden of gastric ulcers globally.
The global gastric ulcers market is primarily driven by factors such as the increasing prevalence of gastric ulcers due to unhealthy lifestyles, rising geriatric population susceptible to gastrointestinal disorders, and the growing use of non-steroidal anti-inflammatory drugs (NSAIDs) that can lead to ulcers. Additionally, the rising awareness about gastrointestinal diseases and the availability of advanced diagnostic and treatment options are contributing to the market growth. Moreover, the introduction of innovative therapies, such as proton pump inhibitors and H. pylori eradication treatments, are further driving the market expansion. The market is also benefiting from ongoing research and development efforts focused on developing novel drugs and treatments for gastric ulcers, ensuring a positive outlook for the market in the coming years.
Government policies related to the Global Gastric Ulcers Market typically focus on promoting research and development of new treatments, ensuring drug safety and efficacy through stringent regulatory processes, and enhancing access to affordable healthcare for patients. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the EU play a crucial role in approving new medications for gastric ulcers, while also monitoring the market for compliance with safety standards. Government healthcare programs and insurance policies also influence the availability and affordability of treatments for gastric ulcers, impacting market dynamics. Additionally, initiatives aimed at raising awareness about preventive measures and early detection of gastric ulcers are often supported by government agencies to reduce the burden of this condition on healthcare systems worldwide.
The Global Gastric Ulcers Market is expected to witness steady growth in the coming years, driven by factors such as the rising prevalence of gastric ulcers due to unhealthy dietary habits, increasing stress levels, and the growing geriatric population. The market is also likely to benefit from advancements in diagnostic techniques and treatment options, as well as a focus on early detection and prevention of gastric ulcers. Additionally, the increasing awareness about gastrointestinal disorders and the availability of innovative therapies are anticipated to further boost market growth. However, challenges such as high treatment costs and the presence of alternative treatment options may hinder the market expansion to some extent. Overall, the Global Gastric Ulcers Market is projected to demonstrate moderate growth opportunities in the foreseeable future.
The Asia Pacific region is expected to witness significant growth in the global gastric ulcers market due to the rising prevalence of Helicobacter pylori infection and changing dietary habits. North America and Europe are anticipated to hold a considerable market share attributed to the increasing geriatric population and higher healthcare expenditure. The Middle East and Africa region is projected to experience moderate growth due to improving healthcare infrastructure and rising awareness about gastrointestinal disorders. Latin America is expected to show steady growth in the market owing to the increasing adoption of advanced medical technologies and a growing focus on healthcare development. Overall, the global gastric ulcers market is poised for growth across all regions, driven by factors such as increasing incidence of gastric ulcers and advancements in treatment options.
Global Gastric Ulcers Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Gastric Ulcers Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Gastric Ulcers Market Revenues & Volume, 2021 & 2031F |
3.3 Global Gastric Ulcers Market - Industry Life Cycle |
3.4 Global Gastric Ulcers Market - Porter's Five Forces |
3.5 Global Gastric Ulcers Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Gastric Ulcers Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Global Gastric Ulcers Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Global Gastric Ulcers Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Global Gastric Ulcers Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Global Gastric Ulcers Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Gastric Ulcers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Gastric Ulcers Market Trends |
6 Global Gastric Ulcers Market, 2021 - 2031 |
6.1 Global Gastric Ulcers Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Gastric Ulcers Market, Revenues & Volume, By Proton Pump Inhibitors (PPI), 2021 - 2031 |
6.1.3 Global Gastric Ulcers Market, Revenues & Volume, By H2 Antagonists, 2021 - 2031 |
6.1.4 Global Gastric Ulcers Market, Revenues & Volume, By Antacids, 2021 - 2031 |
6.1.5 Global Gastric Ulcers Market, Revenues & Volume, By Antibiotics, 2021 - 2031 |
6.1.6 Global Gastric Ulcers Market, Revenues & Volume, By Cytoprotective Agents, 2021 - 2031 |
6.1.7 Global Gastric Ulcers Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Gastric Ulcers Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Gastric Ulcers Market, Revenues & Volume, By Stool Test, 2021 - 2031 |
6.2.3 Global Gastric Ulcers Market, Revenues & Volume, By Endoscopy, 2021 - 2031 |
6.2.4 Global Gastric Ulcers Market, Revenues & Volume, By Imaging Tests, 2021 - 2031 |
6.2.5 Global Gastric Ulcers Market, Revenues & Volume, By CT scan, 2021 - 2031 |
6.2.6 Global Gastric Ulcers Market, Revenues & Volume, By X-ray, 2021 - 2031 |
6.2.7 Global Gastric Ulcers Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2.8 Global Gastric Ulcers Market, Revenues & Volume, By Blood Tests, 2021 - 2031 |
6.2.9 Global Gastric Ulcers Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Gastric Ulcers Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Gastric Ulcers Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Global Gastric Ulcers Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.3.4 Global Gastric Ulcers Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Gastric Ulcers Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Gastric Ulcers Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Gastric Ulcers Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.4.4 Global Gastric Ulcers Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4.5 Global Gastric Ulcers Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Gastric Ulcers Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Gastric Ulcers Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.3 Global Gastric Ulcers Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.5.4 Global Gastric Ulcers Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.5.5 Global Gastric Ulcers Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Gastric Ulcers Market, Overview & Analysis |
7.1 North America Gastric Ulcers Market Revenues & Volume, 2021 - 2031 |
7.2 North America Gastric Ulcers Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Gastric Ulcers Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4 North America Gastric Ulcers Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.5 North America Gastric Ulcers Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Gastric Ulcers Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7 North America Gastric Ulcers Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Gastric Ulcers Market, Overview & Analysis |
8.1 Latin America (LATAM) Gastric Ulcers Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Gastric Ulcers Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Gastric Ulcers Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
8.4 Latin America (LATAM) Gastric Ulcers Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
8.5 Latin America (LATAM) Gastric Ulcers Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.6 Latin America (LATAM) Gastric Ulcers Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.7 Latin America (LATAM) Gastric Ulcers Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Gastric Ulcers Market, Overview & Analysis |
9.1 Asia Gastric Ulcers Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Gastric Ulcers Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Gastric Ulcers Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
9.4 Asia Gastric Ulcers Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
9.5 Asia Gastric Ulcers Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.6 Asia Gastric Ulcers Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.7 Asia Gastric Ulcers Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Gastric Ulcers Market, Overview & Analysis |
10.1 Africa Gastric Ulcers Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Gastric Ulcers Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Gastric Ulcers Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
10.4 Africa Gastric Ulcers Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
10.5 Africa Gastric Ulcers Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.6 Africa Gastric Ulcers Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.7 Africa Gastric Ulcers Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Gastric Ulcers Market, Overview & Analysis |
11.1 Europe Gastric Ulcers Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Gastric Ulcers Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Gastric Ulcers Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
11.4 Europe Gastric Ulcers Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
11.5 Europe Gastric Ulcers Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.6 Europe Gastric Ulcers Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.7 Europe Gastric Ulcers Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Gastric Ulcers Market, Overview & Analysis |
12.1 Middle East Gastric Ulcers Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Gastric Ulcers Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Gastric Ulcers Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Gastric Ulcers Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
12.4 Middle East Gastric Ulcers Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
12.5 Middle East Gastric Ulcers Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.6 Middle East Gastric Ulcers Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.7 Middle East Gastric Ulcers Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Gastric Ulcers Market Key Performance Indicators |
14 Global Gastric Ulcers Market - Export/Import By Countries Assessment |
15 Global Gastric Ulcers Market - Opportunity Assessment |
15.1 Global Gastric Ulcers Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Gastric Ulcers Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
15.3 Global Gastric Ulcers Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
15.4 Global Gastric Ulcers Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.5 Global Gastric Ulcers Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.6 Global Gastric Ulcers Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Gastric Ulcers Market - Competitive Landscape |
16.1 Global Gastric Ulcers Market Revenue Share, By Companies, 2024 |
16.2 Global Gastric Ulcers Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |